Esomeprazole – S-isomer of omeprazole with more favorable pharmacological properties and stronger pharmacodynamic effect
Milan Lukáš Orcid.org 1
+ Affiliation
To read this article in full, please register for free on this website.
Benefits for subscribers
Benefits for logged users
Literature
1. Martínek J, Lukáš M. Inhibitory protonové pumpy – up to date. Gastroent Hepatol 2011; 65 (6): 331–342.
2. Špičák J. Inhibitory protonové pumpy: vedlejší účinky a interakce. Gastroent Hepatol 2013; 67 (4): 289–297.
3. Souhrn údajů o přípravku Pylera. [online]. Dostupné z: www.sukl.cz.
4. Heribanová L. Extraezofageální a gastroezofageální reflux – vztah k astma bronchiale. Gastroent Hepatol 2016; 70 (5): 438–442. doi: 10.14735/amgh2016438.
5. Olbe L, Carlsson E, Lindberg P. A proton-pump inhibitor expedition: the case histories of omeprazole and esomeprazole. Nat Rev Drug Discov 2003; 2 (2): 132–139.
6. Miehlke S, Madisch A, Kirsch C et al. Intragastric acidity during treatment with esomeprazole 40 mg twice daily or pantoprazole 40 mg twice daily – a randomized, two-way crossover study. Aliment Pharmacol Ther 2005; 21 (8) : 963–967.